Press release
Theranostics Market Forecast to Skyrocket, Attaining USD 3,096.47 Million by 2032 with an Astounding CAGR of 10.01% | Key Players- Thermo Fisher Scientific Inc, GE Healthcare, Qiagen NV
Theranostics Market
๐๐๐ฒ ๐๐ญ๐๐ญ๐ฌ
โข The global theranostics market was valued at USD 1,212.39 million in 2022
โข The industry is expected to grow at a CAGR of 10.01% during the forecast period
โข By 2032, the market is expected to reach USD 3,096.47 million
๐๐๐ญ ๐๐จ๐ฎ๐ซ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐จ๐ฐ:
https://www.polarismarketresearch.com/industry-analysis/global-theranostics-market/request-for-sample
๐๐ซ๐จ๐ฐ๐ญ๐ก ๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ ๐๐ง๐ ๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐๐ฌ
The growing prevalence of cancer worldwide is one of the prominent drivers of the market. As cancer cases grow globally, the demand for more customized and productive cures also escalates. The therapy can assist in recognizing particular cancer biomarkers, which can be utilized to customize treatment schemes for distinct patients.
Furthermore, enhancements in imaging technologies, biomarker recognition, and molecular biology have made it feasible to advance more productive theranostics commodities and services. Additionally, governments globally are funding in research and development of theranostics commodities and services driving up the theranostics market demand.
๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐จ๐ง ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ
The market is excessively aggressive, with customary healthcare mammoths communicating in a zestful way to advance consolidated theranostics solutions. Some of the current players in the theranostics market are:
โข F Hoffman La Roche
โข Thermo Fisher Scientific Inc.
โข GE Healthcare
โข Qiagen NV
โข Agilent Technologies
โข Leica Biosystems Nussloch GmBH
โข Pfizer Inc.
โข Foundation Medicine
โข Beckman Coulter Inc.
โข Focus Diagnostics
โข Illumina Inc.
โข Myriad Genetics Inc.
โข AmeriPath Inc.
โข Abbott Laboratoriesl
๐๐๐๐ ๐๐จ๐ซ๐ ๐๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง? ๐๐ง๐ช๐ฎ๐ข๐ซ๐ ๐ฆ๐จ๐ซ๐ ๐๐๐จ๐ฎ๐ญ ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐๐๐๐จ๐ซ๐ ๐ฉ๐ฎ๐ซ๐๐ก๐๐ฌ๐: https://www.polarismarketresearch.com/industry-analysis/global-theranostics-market/inquire-before-buying
๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ
โข North America held a dominant position in the global market due to the growing demand for tailor-made medicine and the growing existence of detrimental illnesses. The existence of prominent market players and entrenched healthcare frameworks is anticipated to push market growth.
โข Asia Pacific is anticipated to develop at the quickest rate in the market over the forecast period due to the growing demand for customized medicines and the growing existence of detrimental illnesses.
๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง
Theranostics Market, Disease Outlook (Revenue - USD Million, 2019 - 2032)
โข Neurological Disorders
โข Cardiovascular Diseases
โข Oncology Disorders
โข Immunological Disorders
Theranostics Market, Technology Outlook (Revenue - USD Million, 2019 - 2032)
โข Polymerase Chain Reaction (PCR)
โข In Situ Hybridization (ISH)
โข Immunohistochemistry (IHC)
โข Sequencing
Theranostics Market, End-User Outlook (Revenue - USD Million, 2019- 2032)
โข Hospitals and Clinics
โข Diagnostics Laboratories
โข Others
๐๐ข๐ฏ๐ ๐๐ง๐ญ๐จ ๐ญ๐ก๐ ๐๐๐ญ๐๐ข๐ฅ๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ซ๐: https://www.polarismarketresearch.com/industry-analysis/global-theranostics-market
๐๐ก๐๐ซ๐๐ง๐จ๐ฌ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ
โข The Oncology Disorders segment accounted for the largest market share in 2022. Overall, the oncology segment of the theranostics market is expected to continue to grow, driven by increasing awareness of personalized medicine and advances in molecular diagnostics and targeted therapies.
โข Based on Technology, the Polymerase Chain Reaction (PCR) segment is anticipated to grow quickly over the forecast period. The PCR segment of the theranostics market is expected to continue to grow, driven by the increasing demand for rapid and accurate diagnostic tests and the development of new PCR-based technologies, such as digital PCR and droplet digital PCR.
โข The Hospitals and Clinics segment is accounted to witness the fastest growth rate in the forecast period. The segment growth can be attributed to various factors such as rising number of theranostics patients requiring the diagnosis treatment.
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐๐๐'๐ฌ ๐๐ฑ๐ญ๐๐ง๐ฌ๐ข๐ฏ๐ ๐จ๐ง๐ ๐จ๐ข๐ง๐ ๐๐จ๐ฏ๐๐ซ๐๐ ๐ ๐จ๐ง ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐๐จ๐ฆ๐๐ข๐ง:
Gene Therapy Market: https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market
Hearing Aids Market: https://www.polarismarketresearch.com/industry-analysis/global-hearing-aids-market
Medical Tourism Market: https://www.polarismarketresearch.com/industry-analysis/medical-tourism-market
Medical Disposable Market: https://www.polarismarketresearch.com/industry-analysis/medical-disposable-market
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Theranostics Market Forecast to Skyrocket, Attaining USD 3,096.47 Million by 2032 with an Astounding CAGR of 10.01% | Key Players- Thermo Fisher Scientific Inc, GE Healthcare, Qiagen NV here
News-ID: 3663487 • Views: โฆ
More Releases from Polaris Market Research & Consulting
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of โฆ
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. Itโฆ
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 โฆ
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 3.82 billion in 2024 and is expected toโฆ
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin โฆ
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billionโฆ
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 โฆ
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 31.67 billion in 2024 and is expected to reachโฆ
More Releases for Theranostics
Theranostics Market in 2025 Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Theranostics Market -(Product (Diagnostic imaging, Radiopharmaceuticals, Biomarker screening and Software), Application (Prostate Cancer, Bone Metastasis, Other Cancers, Other Application), End-user (Hospitals & Cancer Care Centers, Theranostics Centers, and Research & Academic Centers)) Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Theranostics Market Size is valuedโฆ
Rising Cancer Prevalence Fuels Growth In The Theranostics Market Driver: Leading โฆ
What combination of drivers is leading to accelerated growth in the theranostics market?
The theranostics market is forecasted to grow due to an upward trend in cancer cases. Cancer, a disease characterized by unchecked cell growth affecting numerous organs, is a leading cause of considerable illness and death globally. Theranostics, combining therapeutic and diagnostic aspects, holds significant prospects in managing cancer and chronic illnesses. This methodology paves the way for tailoredโฆ
Theranostics Market worth $4.3 billion by 2028
The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall theranostics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies.
Theranostics Market [https://www.marketsandmarkets.com/Market-Reports/theranostics-market-111696976.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] in terms of revenue was estimated to be worth $2.1 billion in 2023 and is poised to reach $4.3โฆ
Theranostics Market Worth $4.3 Billion | MarketsandMarkets Trademark
Theranostics Market in terms of revenue was estimated to be worth $2.1 billion in 2023 and is poised to reach $4.3 billion by 2028, growing at a CAGR of 15.5% from 2023 to 2028
Theranostics Market [https://www.marketsandmarkets.com/Market-Reports/theranostics-market-111696976.html?utm_source=Prnewswire&utm_medium=referral&utm_campaign=paidpr] in terms of revenue was estimated to be worth $2.1 billion in 2023 and is poised to reach $4.3 billion by 2028, growing at a CAGR of 15.5% from 2023 to 2028 according toโฆ
Theranostics Market: Pioneering Precision Medicine into 2030
The Theranostics Market was valued USD 1.9 Billion in 2023 and projected to reach USD 5.4 Billion by 2030, growing at a CAGR of 16.2% during the forecast period of 2024-2030.
The Theranostics Market report studies the competitive environment of the Theranostics Market based on company profiles and their efforts to increase product value and production. The Theranostics Market report discusses various factors driving or restraining the market, which will helpโฆ
Theranostics Market Is Booming Worldwide Just Published
Global Theranostics Market: An Overview
Theranostics is a new field of medicine which relies on targeted therapies to conduct specific targeted tests. These tests are mainly used for various forms of cancers. The key concern in the therapeutics involve patient centric care with the help of more personalised and precise approach. The technique relies on the use of diagnostic and therapeutic applications to form a single agent. The system is knownโฆ
